Procaps Group Sa Share Price: PROC (Procaps Group Sa) Stock Price Today & Updates | INDmoney

Question 1

What is Procaps Group Sa share price today?

Accepted Answer

Procaps Group Sa (PROC) share price today is {{live_price}}.

Question 2

Can Indians buy Procaps Group Sa shares?

Accepted Answer

Yes, Indians can invest in the Procaps Group Sa (PROC) from India.

With INDmoney, you can buy Procaps Group Sa at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Procaps Group Sa at zero transaction cost.

Question 3

How can I buy Procaps Group Sa shares from India?

Accepted Answer

It is very easy to buy Procaps Group Sa from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Procaps Group Sa be purchased?

Accepted Answer

Yes, you can buy fractional shares of Procaps Group Sa with INDmoney app.

Question 5

What are the documents required to start investing in Procaps Group Sa stocks?

Accepted Answer

To start investing in Procaps Group Sa, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Procaps Group Sa

Accepted Answer

Today’s highest price of Procaps Group Sa (PROC) is {{1_rba_end}}.

Today’s lowest price of Procaps Group Sa (PROC) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Procaps Group Sa

Accepted Answer

Today's market capitalisation of Procaps Group Sa PROC is 307.7M

Question 8

What is the 52 Week High and Low Range of Procaps Group Sa

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Procaps Group Sa is down from its 52 Week High?

Accepted Answer

Procaps Group Sa (PROC) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Procaps Group Sa is up from its 52 Week low?

Accepted Answer

Procaps Group Sa (PROC) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Procaps Group Sa?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Procaps Group Sa

Accepted Answer

Mr. Ruben  Minski is the current Chief Executive Officer (CEO) of Procaps Group Sa.

Period	Procaps Group Sa	Sector (Health Care)	Index (Russel 2000)
3 Months	-22.74%	-0.8%	0.0%
6 Months	-7.54%	10.5%	0.0%
1 Year	-38.16%	6.4%	2.9%
3 Years	-72.35%	14.6%	-21.3%

Market Capitalization	307.7M
Book Value	$0.39
Earnings Per Share (EPS)	0.51
PE Ratio	5.35
Wall Street Target Price	4.75

Profit Margin	12.61%
Operating Margin TTM	11.13%

Return On Assets TTM	6.28%
Return On Equity TTM	37.37%

Revenue TTM	414.1M
Revenue Per Share TTM	4.1
Quarterly Revenue Growth YOY	7.3%
Gross Profit TTM	191.3M
EBITDA	57.1M
Diluted Eps TTM	0.51
Quarterly Earnings Growth YOY	-0.64

Procaps Group Sa (PROC)

Increasing Revenue

Decreasing Net Profit

Vs NBIX

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	0.31
EPS Estimate Next Year	0.27
EPS Estimate Current Quarter	0.0
EPS Estimate Next Quarter	0.0

	FY20	Y/Y Change
Revenue	331.5M	↑ 2.06%
Net Income	-10.4M	↓ 38.59%
Net Profit Margin	-3.15%	↑ 2.09%

	FY21	Y/Y Change
Revenue	409.7M	↑ 23.61%
Net Income	-100.9M	↑ 865.47%
Net Profit Margin	-24.62%	↓ 21.47%

	FY22	Y/Y Change
Revenue	409.9M	↑ 0.04%
Net Income	42.5M	↓ 142.18%
Net Profit Margin	10.38%	↑ 35.0%

	FY23	Y/Y Change
Revenue	414.1M	↑ 1.02%
Net Income	52.2M	↑ 22.72%
Net Profit Margin	12.61%	↑ 2.23%

	Q2 FY22	Q/Q Change
Revenue	112.4M	↓ 11.16%
Net Income	-6.9M	↓ 85.05%
Net Profit Margin	-6.15%	↑ 30.43%

	Q3 FY22	Q/Q Change
Revenue	110.4M	↓ 1.79%
Net Income	22.6M	↓ 426.35%
Net Profit Margin	20.45%	↑ 26.6%

	Q4 FY22	Q/Q Change
Revenue	101.5M	↓ 8.09%
Net Income	10.4M	↓ 53.79%
Net Profit Margin	10.28%	↓ 10.17%

	Q1 FY23	Q/Q Change
Revenue	101.5M	↑ 0.0%
Net Income	10.4M	↑ 0.0%
Net Profit Margin	10.28%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	118.4M	↑ 16.7%
Net Income	8.2M	↓ 21.47%
Net Profit Margin	6.92%	↓ 3.36%

	FY19	Y/Y Change
Total Assets	337.7M	-
Total Liabilities	581.7M	-

	FY20	Y/Y Change
Total Assets	359.5M	↑ 6.46%
Total Liabilities	614.2M	↑ 5.59%

	FY21	Y/Y Change
Total Assets	462.1M	↑ 28.54%
Total Liabilities	500.5M	↓ 18.52%

	FY22	Y/Y Change
Total Assets	460.2M	↓ 0.42%
Total Liabilities	462.1M	↓ 7.67%

	Q4 FY22	Q/Q Change
Total Assets	84.4M	↓ 82.08%
Total Liabilities	145.4M	↓ 69.81%

	Q1 FY23	Q/Q Change
Total Assets	460.2M	↑ 445.04%
Total Liabilities	462.1M	↑ 217.75%

	FY19	Y/Y Change
Operating Cash Flow	68.3M	-
Investing Cash Flow	-12.1M	-
Financing Cash Flow	-46.9M	-

	FY20	Y/Y Change
Operating Cash Flow	70.9M	↑ 3.86%
Investing Cash Flow	-17.1M	↑ 41.61%
Financing Cash Flow	-40.5M	↓ 13.72%

	Q2 FY22	Q/Q Change
Operating Cash Flow	10.0M	↓ 61.68%
Investing Cash Flow	-8.9M	↑ 114.28%
Financing Cash Flow	-26.0M	↓ 55.14%

	Q3 FY22	Q/Q Change
Operating Cash Flow	5.8M	↓ 42.21%
Investing Cash Flow	-7.5M	↓ 16.3%
Financing Cash Flow	-5.4M	↓ 79.41%

	Q4 FY22	Q/Q Change
Operating Cash Flow	-7.9M	↓ 238.01%
Investing Cash Flow	-5.0M	↓ 32.62%
Financing Cash Flow	27.9M	↓ 620.91%

	Q2 FY23	Q/Q Change
Operating Cash Flow	47.4M	↓ 696.6%
Investing Cash Flow	-7.9M	↑ 56.65%
Financing Cash Flow	-29.9M	↓ 207.01%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Procaps Group Sa	-1.05%	-7.54%	-38.16%	-72.35%	-72.35%
Neurocrine Biosciences Inc.	2.25%	23.42%	46.82%	53.78%	76.99%
Haleon Plc Spon Ads	0.85%	2.34%	-3.82%	12.01%	12.01%
Zoetis Inc.	0.94%	2.39%	-6.39%	-3.86%	61.69%
Viatris Inc.	0.17%	27.9%	30.6%	-12.09%	-27.91%
Catalent, Inc.	-0.81%	64.82%	14.77%	-45.41%	21.48%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Procaps Group Sa	Buy	$307.7M	-72.35%	5.35	12.61%
Neurocrine Biosciences Inc.	Buy	$14.1B	76.99%	56.26	13.23%
Haleon Plc Spon Ads	Buy	$38.4B	12.01%	30.0	9.28%
Zoetis Inc.	Buy	$68.9B	61.69%	29.76	27.43%
Viatris Inc.	Hold	$13.6B	-27.91%	229.4	0.35%
Catalent, Inc.	Hold	$10.1B	21.48%	211.02	-31.77%

Organization	Procaps Group Sa
Employees	5500
CEO	Mr. Ruben Minski
Industry	Financial